Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Aservo® EquiHaler® now available in the UK and Ireland
The inhaler marks more than a decade of collaboration between human pharma and animal health businesses.

Product allows medication to be inhaled deep into horses’ lungs.
 
The first inhaled treatment for severe equine asthma is now available in the UK and Ireland.

Manufactured by Boehringer Ingelheim, the Aservo® EquiHaler® marks more than a decade of collaboration between human pharma and Boehringer’s animal health business.

The inhaler incorporates Soft Mist Technology®, which is found in the Respimat® inhaler used in human respiratory disease. This allows the active ingredient to be inhaled deep into the horses’ lungs.

"It's another industry first and is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation,” commented Dr Marc Laemmer, head of equine in UK & Ireland.

“We understand that a product launch in this challenging time for the veterinary profession may seem surprising, but we have had such strong demand from equine vets for the product that we have committed to making Aservo® EquiHaler® available. Our team of territory managers and vet advisers will conduct remote meetings with customers to make sure that they have the information and support they require.”

He continues: “The launch of Aservo® EquiHaler® is a prime example of leveraging innovation efforts of both our human and animal businesses. This has been a strength of ours and I'm excited that we are continuing to further increase the delivery of innovative solutions for horse owners and vets."

The active ingredient in the Aservo® EquiHaler® is ciclesonide - a corticosteroid that is activated directly in the lung, reducing the lower airway inflammation associated with severe equine asthma and reducing the risks commonly associated with systemic corticosteroids.

It does not use a propellant, meaning that using the device does not contribute to harmful greenhouse gas emissions. It has also been manufactured from 50 per cent recycled materials.

Featuring an ergonomic handle, dosing lever, and nostril adapter, the Aservo® EquiHaler®  has been awarded the prestigious Red Dot Award for Product Design.



Become a member or log in to add this story to your CPD history

Zoo calls for volunteers in its hour of need

News Story 1
 As ZSL London Zoo begins to get back on its feet, the organisation is putting out a call for volunteers who have time to help out. It comes after three months of unprecedented closure, which has seen zoos across the UK come under enormous financial pressure.

Volunteers will be required to commit to a minimum of half a day each fortnight, helping to assist zoo visitors as they make their way around. Volunteer manager Rhiannon Green said: "We need cheery, flexible people who can help visitors enjoy their day while respecting the measures that keep everyone safe.

For more information, visit zsl.org. Posts are available at both London and Whipsnade Zoos. 

Click here for more...
News Shorts
BSAVA webinars to shine the spotlight on selected journal papers

A free series of webinars that take a closer look at selected papers published in the Journal of Small Animal Practice has been produced by the BSAVA.

In the new BSAVA Science webinar series, authors of the featured papers discuss their results with a panel and how they may impact clinical practice. The authors then answer questions submitted by audience members.

The webinars are available via the BSAVA Webinar Library, covering four different papers. JSAP editor Nicola Di Girolamo, said: "Discussing the research with the authors - experts in their field - really helps to bring the papers to life."